January 16, 2018 / 1:34 PM / in 10 months

BRIEF-Bayer: FDA Report Reaffirms Safety Profile And Effectiveness Of Xarelto In Routine Clinical Practice

Jan 16 (Reuters) - BAYER AG:

* FDA REPORT REAFFIRMS SAFETY PROFILE AND EFFECTIVENESS OF BAYER'S XARELTO IN ROUTINE CLINICAL PRACTICE Source text: bit.ly/2DDuMIB Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below